Diagnosis and treatment

President Donald Trump talks to reporters on the South Lawn of the White House before departing for his Bedminster, N.J. golf club, Friday, July 5, 2019, in Washington. (AP Photo/Evan Vucci)
July 05, 2019 - 10:04 am
WASHINGTON (AP) — President Donald Trump is promising an executive order that he says is intended to enable the U.S. government to pay lower prices for prescription drugs. Trump says his administration soon would announce a "favored-nations clause," where the amount paid by the government for a...
Read More
Britain's Andy Murray, right, and Pierre-Hugues Herbert of France celebrate after winning their Men's doubles match during day four of the Wimbledon Tennis Championships in London, Thursday, July 4, 2019. (AP Photo/Tim Ireland)
July 04, 2019 - 1:37 pm
WIMBLEDON, England (AP) — The Latest at Wimbledon (all times local): 9:30 p.m. Andy Murray won his opening match at this year's Wimbledon tournament, in men's doubles. The two-time singles champion at the All England Club teamed with Pierre-Hugues Herbert to beat Marius Copil and Ugo Humbert 4-6, 6...
Read More
In this April 8, 2019, photo Chuck Pope, left, and wife Nina talk about his ongoing battle with rheumatoid arthritis and trying to afford medications to alleviate the condition while at their home in Derry, Pa. Pope had been battling the disease with an injected drug that his insurance covered while he was still working. It relieves pain and stops irreversible joint damage but retails for over $5,000 a month. Now his Medicare plan doesn't cover that drug, and Pope says his condition is deteriorating without it. Meanwhile, sales of approved, cheaper versions have been blocked. (AP Photo/Keith Srakocic)
June 27, 2019 - 7:39 am
TRENTON, N.J. (AP) — Injected drugs known as biosimilars were expected to save the U.S. health care system tens of billions of dollars. But sales have been so limited that their future is in doubt. Biologic medicines treat cancer, rare diseases and autoimmune disorders like rheumatoid arthritis and...
Read More
June 26, 2019 - 1:19 pm
BATON ROUGE, La. (AP) — For years, Louisiana offered hepatitis C treatment to only the most severe cases in its Medicaid program and prisons, unable to afford broader access to the extremely high-priced medications. That will change in July, when the state begins a first-in-the-nation treatment...
Read More
In this June 5, 2009, photo a woman has Botox injected at Reveal in Arlington, Va. AbbVie is buying Botox maker Allergan in a cash-and-stock deal the drugmakers value at around $63 billion. The maker of the blockbuster immune disorder treatment Humira said Tuesday, June 25, 2019, that it will pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. (AP Photo/Jacquelyn Martin, File)
June 25, 2019 - 11:39 am
Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth. Specialty drugmaker AbbVie said Tuesday that adding Allergan's aesthetics products and eye care...
Read More
FILE – In this Jan. 11, 2018, file photo, U.S. District Judge Dan Polster poses for a portrait in his office in Cleveland. Polster is holding a hearing Tuesday, June 25, 2019, in Cleveland on a plan pitched by lawyers for local governments on distributing money to nearly 25,000 municipal and county governments. The plan would take effect if companies that make and distribute the powerful prescription painkillers agree to one or more legal settlements. (AP Photo/Tony Dejak, File)
June 25, 2019 - 11:20 am
CLEVELAND (AP) — State and local governments suing over the toll of a nationwide opioid crisis agree that companies in the drug industry should be held accountable, but they have differences on who should have the power to strike any settlement, and how it should work. Those disputes had been...
Read More
FILE - This July 6, 2018, file photo shows boxes containing petitions in favor of a proposal to legalize casinos in Arkansas, delivered to the Arkansas secretary of state's office in Little Rock, Ark. Voters in several states dominated politically by Republicans have passed ballot initiatives in recent years to expand Medicaid, legalize marijuana, raise the minimum wage and reform the redistricting process. This has led several GOP legislatures and governors to begin cracking down on the initiative process in ways that will make it harder for the public to quality ballot measures. (AP Photo/Andrew Demillo, File)
June 22, 2019 - 11:12 am
LITTLE ROCK, Ark. (AP) — Arkansas voters have been active in recent years, passing ballot initiatives that legalized medical marijuana, raised the minimum wage and expanded casino gambling. That hasn't gone over well with Republicans. Arkansas' GOP-dominated Legislature has taken steps this year...
Read More
FILE - In this May 3, 2019 file photo, South Africa's Caster Semenya competes in the women's 800-meter final during the Diamond League in Doha, Qatar. Court documents released publicly for the first time this week reveal previously hidden details of Caster Semenya's 10-year battle with the international track body. In them, the two-time Olympic 800-meter champion said the IAAF accused her of intentionally running slowly at times to mask the alleged advantage she has from her elevated natural testosterone. She angrily denied the accusation. (AP Photo/Kamran Jebreili)
June 22, 2019 - 9:27 am
Caster Semenya was accused by the IAAF of intentionally running slowly at times to mask her alleged advantage from elevated natural testosterone, according to recently released court documents. Semenya angrily denied the accusation. The exchange was included in 163 pages of court records from the...
Read More
June 21, 2019 - 3:01 pm
WASHINGTON (AP) — U.S. women will soon have another drug option designed to boost low sex drive: a shot they can give themselves in the thigh or abdomen that raises sexual interest for several hours. The medication OK'd Friday by the Food and Drug Administration is only the second approved to...
Read More
FILE - In this Aug. 17, 2018 file photo, family and friends who lost loved ones to opioid overdoses protest outside the headquarters of Purdue Pharma, maker of the maker of painkiller OxyContin, in Stamford, Conn. The World Health Organization notified U.S. lawmakers Wednesday, June 19, 2019, that it will discontinue two publications on opioid painkiller prescribing, in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines - viewed around the world as best practices in public health - comes a month after U.S. Reps. Katherine Clark and Hal Rogers accused the WHO of being influenced by Purdue. The lawmakers’ report claimed the guidelines were crafted by organizations with financial ties to the company, who worked to downplay risks addiction and overstate the benefits of opioids. Purdue has denied the allegations. (AP Photo/Jessica Hill, File)
June 19, 2019 - 6:03 pm
The World Health Organization has notified U.S. lawmakers that it will discontinue two publications on prescribing opioid painkillers in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines comes a month after U.S. Reps. Katherine...
Read More

Pages